Nik received his BSc (Biochemistry & Genetics) and his PhD at the University of Leeds. This was followed by a post-doctoral fellowship at the Cancer Research UK Centre (St Jamesâ€™ Hospital, Leeds) and an EPSRC-funded fellowship in the Jack Birch Unit of Molecular Carcinogenesis (University of York). Following that, he moved to the Department of Biological Sciences at the University of Huddersfield where he is currently a Reader (Associate Professor) in Cell Biology.
Nik Georgopoulos(Research Area)
Nikâ€™s research focuses on understanding how the process of epithelial cancer development influences proliferation/growth, differentiation and particularly cell responses to death signals triggered by members of the TNF Receptor (TNFR) family of proteins. The aim is to use such knowledge to design novel, tumour-specific anticancer therapies. Currently he is developing a novel platform of cancer therapeutics based on the TNFR family (ThanatoCureâ„¢). His skin-related research involves using biological models to explore, at the cellular and molecular level, the underlying mechanisms of defective wound healing and chemotherapy-induced alopecia. This will permit the improvement of existing medical devices and design of novel technologies to provide improved therapeutic intervention strategies. Nik has a major industrial collaboration on skin-related research with Paxman (http://paxman-coolers.com).
Khalid Matin, M.D., F.A.C.P., has been appointed as a medical director of community oncology and clinical research affiliations at VCU Massey Cancer Center and an associate professor in the Division of Hematology, Oncology and Palliative Care, Department of Internal Medicine, at the VCU School of Medicine, effective July 15, 2013. Most recently, Matin was director of community oncology and associate professor of oncology at Roswell Park Cancer Institute in Buffalo, New York. He was also an attending physician at Roswellâ€™s satellite facility in Amherst, NY. Prior to his roles at Roswell, Matin was a medical oncologist at the Cancer Center of Montgomery, Alabama, which is part of the Southeast Cancer Network; a clinical assistant professor at the University of Alabama in Birmingham and University of Pittsburgh Cancer Institute in Pennsylvania; and attending physician in hematology-oncology at the Veterans Affairs Medical Center in Pittsburgh. A board-certified medical oncologist and clinical researcher, Matin is an expert in the study and treatment of gastrointestinal (GI) cancers. He has developed several clinical trials for GI cancers, and he has served as the principal investigator and co-investigator on various colorectal and lung cancer trials.
Khalid Matin(Research Area)
Matin is an expert in the study and treatment of gastrointestinal (GI) cancers. He has developed several clinical trials for GI cancers and lung cancer.
Professor Ioannis S. Patrikios received his BSc degree in Pre-Medical studies/Biochemistry from the City College of the City University of NY. He completed his PhD studies in 1994, specialized on Immunology and Lipids/Lipidomics and post-doctoral studies specialization in Medical Biochemistry at the City College of NY, next to the world-known Professor CS Russell. Professor Patrikios went through several different fellowships including research specializations /collaborations with different high reputation institutions including, Mount Sinai NY and was awarded advanced Immunology specialization courses at Scuola Superiore d'Immunologia Ruggero Ceppellini, Italy. He served and continues to serve as a Research Scientific Consultant for Industry and higher education. His broad research interests include studies of new therapeutic approaches of chronic diseases by the use of Systems Medicine, through Systems Biology and Nutritional Systems Biology; Lipid Hemagglutinins, Lectins, Immunology and the use of novel interventions against Metastatic Tumor Cells. As from 2004, Professor Patrikios got involved in the research of innovative, pioneer, holistic therapeutic approaches for chronic multifactorial Neurodegenerative diseases, specifically of Multiple Sclerosis. He is affiliated as a Graduate Studies Mentor with the Institute of Brain Chemistry of London. During the last decade he has obtained many competitive research grants, participated in several different collaborative European scientific research-projects and he organized several large European Consortium Platforms for research and Clinical Trials. His 2002 research findings on the effect of frying oils as human hemagglutinins got an international interest; and have been discussed by several different National Food and Drug Administrations, including UK, and through articles in high impact Magazines such as the New Scientist. He has lately been honored with the tittle of a fellow and member of the advisory board of the Forensic Pathology Academy of London. He has been appointed as a reviewer and editor of several international scientific journals in the field of Medicine, Med-Biochemistry, Pharmaceuticals-Therapeutics and Neurology and as a reviewer for research grants. He is the solid author of University Books in Biochemistry and Medical Biochemistry and he has authored numerous peer-reviewed, limited co-authored original publications, in high impact factor scientific journals. Professor Patrikios is a member of several International associations and bodies including Sigma Xi. He is the chief scientific investigator of the team which lately invented and patented the nutraceutical formula PLP10 as a new therapeutic intervention for multiple sclerosis. He is the co-founder and Director of PALUPA Medical Ltd (a research and innovation company), that performed and successfully completed the phase II clinical trial for PLP10. Now he is the scientific coordinator of the â€œMINERALâ€ phase III multicenter clinical trial for PLP10. At present he is a Professor, Faculty of Medicine and the Chairman of the School of Medicine of the European University of Cyprus and affiliated as a research collaborator at the Cyprus Institute of Neurology and Genetics.
Ioannis S. Patrikios (Research Area)
His 2002 research findings on the effect of frying oils as human hemagglutinins got an international interest, and have been discussed by several different National Food and Drug Administrations
Oliver Micke has completed his PhD at the age of 35 years from Muenster University Hospital in 2006. He is head of the Head of the department for radiotherapy and radiation oncology at the Franziskus Hospital Bielefeld since 2006. In addition, he is the medical director of Franziskus Hospital Bielefeld, a premier teaching hospital of the Medical University of Hanover (MHH).
He has published more than 200 papers in reputed national and international journals and has been serving as a reviewer as well as an editorial board member of repute.
Oliver Micke(Research Area)
Radiation Oncology, Breast Cancer, Prostate Cancer, Modern and Advanced Radiotherapy Treatment Techniques, Reirradiation, Cytoprotection, Radiotherapy for Rare Diseases, Radiotherapy for Benign Disorders, Complementary and Alternative Medicine, Selenium, Magnesium, Trace Elements and Electrolytes
Dr Adhip P.N. Majumdar received his MS and PhD degrees from the University of London, England, and D.Sc (Doctor of Science) degree in Gastroenterology from the University of Aarhus, Denmark. Dr. Majumdar has been a Professor at Wayne State University since 1992 and holds the post of Senior Research Career Scientist at the Detroit VA Medical Center. He has published over 200 original scientific articles and a multitude of book chapters/review articles. Dr.Majumdar's lab is particularly interested in elucidating the patho-physiology of age-related changes in the GI mucosa specifically those that lead to malignancy. To this end, Dr Majumdar has been investigating the role of pluripotent, self-renewing CSCs in the development and progression of GI malignancies. Dr Majumdar has been funded by the VA and NIH.
Adhip Majumdar(Research Area)
Role of pluripotent, self-renewing CSCs in the development and progression of GI malignancies.
Dr Gallucci has completed his Specialization in Urology at â€œSapienzaâ€ University of Rome, Dept. of Urology. He is Director of the Department of Oncologic Urology at â€œ Regina Elenaâ€ National Cancer Institute of Rome, since 2001. He has published more than 200 papers in reputed journals, most of them concerning the urological cancers. His main clinical activity is focused on the surgical treatment of urological malignancies.
Dr Hari K Koul completed his PhD in Biochemistry at the Post Graduate Institute of Medical Education and Research (PGI), Chandigarh India and postdoctoral studies from University of Massachusetts Medical School, Worcester, MA. He is Fellow of American Society of Nephrology, Fellow of American College of Nutrition and Overseas Fellow of the Royal Society of Medicine, England and immediate past President of The Society of Basic Urologic Research (SBUR)-USA. He has served as Professor at University of Colorado (2003-2013). He has published more than 60 papers in reputed journals and is the Professor, Carroll W. Feist Endowed Chair, Department of Biochemistry and Molecular Biology, and Director of Research at the Feist Weiller Cancer Center at Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Dimitrios H. Roukos, MD, PhD, is Professor of Surgery â€“ Precision Cancer Medicine and Founding director of â€œCentre for Biosystems and Genome Network Medicineâ€ in the Ioannina University, School of Medicine. His translational and clinical research from traditional and single gene investigation to molecular networks and clinical cancer genome NGS analysis has been recognized by international scientific community. He has published > 236 PubMed papers with recent focus on NGS conventional and breakthrough genome analysis (> 80 articles) and more recently in precision cancer medicine (31 articles). These publications have received more than 8420 citations with h-index: 72 (Scopus). He is reviewer in many high impact journals including some with impact factor (IF) >30, evaluator in innovative research projects (EU, France, Belgium, Luxemburg, Poland), and member in the editorial board of 25 international journals with IF. He has been invited a speaker in many international and world congresses.
Dimitris Roukos(Research Area)
His translational and clinical research from traditional and single gene investigation to molecular networks and clinical cancer genome
Dr Cihangir Akyol graduated from Gazi University School of Medicine in 2002. He completed general surgery residency program at Ankara University School of Medicine in 2008. During his residency, he attended â€œUpper and lower gastrointestinal endoscopyâ€ program in Ankara University. Dr Akyol completed his mandatory government service at Sungurlu State Hospital between September 2008 and June 2010 as the Chief of Surgery and Emergency Departments. In June 2010 he started working at Ankara University Surgery Department as a consultant surgeon. In 2014 he was granted a travel award from the Turkish Society of Colon and Rectal Surgery to visit the Cleveland Clinic Digestive Disease Institute Department of Colorectal Surgery in Ohio, the USA for 3 months. During his visit, he completed robotic surgery courses on animal models. He has been promoted to associate professor of surgery in the section of colorectal surgery, at Ankara University School of Medicine. He is also board certified by European Society of Colo-proctology since 2016.
His main interests are colorectal surgery and minimally invasive surgery including both laparoscopic and robotic surgery. His main career objective is to develop himself as a lifelong proactive learner- through following up the latest advances in colorectal surgery, minimally invasive surgery, and gastrointestinal endoscopy, besides active involvement in experimental research for promotion of the surgical knowledge and skills.
Cihangir Akyol(Research Area)
His main interests are colorectal surgery and minimally invasive surgery including both laparoscopic and robotic surgery.
Dr. Ryan S. Robetorye received his M.D. and PhD degrees from Baylor College of Medicine in Houston, Texas. He is board certified in Clinical Pathology, Hematology, and Molecular Genetic Pathology and currently works as a Consultant at the Mayo Clinic in Phoenix, Arizona. He currently serves as the Medical Director of the clinical laboratories at the Mayo Clinic. His research interests primarily involve haematological malignancies and molecular diagnostics involving gene expression profiling and next-generation sequencing.
Ryan S. Robetorye(Research Area)
primarily involve haematological malignancies and molecular diagnostics involving gene expression profiling and next-generation sequencing.
I'm 63 years old and I've been trained for 40 years in general surgery and head and neck surgery. Teaching residents since 1982 and I was professor and head of the head and neck surgery service of the medical school Catholic University in Campinas, Brazil for 23 years. I am currently director of the Sao Leopoldo Mandic medical school in the city of Araras, Brazil.
Dr. Andrei Bakin is currently Associate Professor in the Department of Cancer Genetics at Roswell Park Cancer Institute. Dr. Andrei Bakin has received a doctoral degree from Lomonosov University, Moscow. He was trained in cancer research with Dr. Tom Curran at St. Jude Childrenâ€™s Research Hospital, and in breast cancer with Dr. Carlos Arteaga at Vanderbilt University. Dr. Bakin has done pioneering studies on EMT in cancer progression. His group has identified novel therapeutic targets driving metastasis. He has mentored over ten graduate students. He is also a member of Editorial Board of scientific journals and active member of AACR.
Andrei Bakin(Research Area)
tumor microenvironment, breast cancer, angiogenesis, tumor-associated fibroblasts, TGF-beta, metastasis, invasion
Dr.Francesco Izzo received his medical degree from the University of Naples, Federico II Medical School, Italy. He completed a general surgery residency at the University of Naples, Italy and then completed a fellowship in Surgical Oncology at the University of Texas Anderson Cancer Center. Dr. Izzo has been on the faculty in the Department of Surgical Oncology at the National Cancer Institute of Naples, Italy since completing his fellowship. He is now Full Professor of Surgery, Director and Coordinator of the Abdominal and Hepatobiliary Surgical Oncology Division and Chief of Liver Tumor Study Group at the National Cancer Institute of Naples, Italy.
Dr. Izzoâ€™s clinical practice and research focuses on surgical oncology new treatments particularly for patients with Hepatobiliary and pancreatic tumors.
Dr.Izzo has been a pioneer in designing new treatments for patients with liver tumors, including radiofrequency ablation, improved techniques for surgical removal of liver cancers, and several types of direct tumor injection therapy.
Dr Izzo is principal investigator on a number of National and International protocols for the basic science and clinical treatment on primary and metastatic hepato-biliary cancers
Dr.Izzo is the author or co-author of over 220 publications, 20 book chapters, many dealing with the treatment of patients with hepatocellular cancer, gallbladder cancer, bile duct cancer, pancreatic cancer or metastases from a number of different tumor types. Is Total Impact Factor: 638,003 ; H-INDEX: 35; Sum of the times cited: 7.017; Database utilized: SCOPUS for H-Index and Bibliosan for IF
Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded MD. In 1985, Suchkov maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology. In 2001, Suchkov maintained his Doctor Degree at the National Institute of Immunology, Russia.
From 1989 through 1995, Dr Suchkov was being a Head of the Lab of Clinical Immunology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004 - a Chair of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI). In 1993-1996, Dr Suchkov was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK.
Sergey V. Suchkov(Research Area)
Immunochemical characteristics of three novel reina-specific antigens in humans and some mammals, Serology in ophthalmic oncology - findings and outlook for the future, Catalytic antibodies in immune-mediated disorders, Clinical and immune-mediated syndrome (CAIMS) in clinical practice: features and strate-gies in immune and molecular diagnostics